Massachusetts Governor Maura Healey has proposed a significant change to the state’s medical marijuana program that would allow certain military veterans to qualify for a medical cannabis card using official Department of Veterans Affairs documentation instead of obtaining a separate cannabis certification from a Massachusetts healthcare provider. The proposal is contained in House Bill 5679, a supplemental budget package filed by the governor on September 23, 2026. Healey’s administration describes the provision as an effort to remove obstacles facing veterans who obtain their medical care through the federal VA system.
If enacted, the change could close a longstanding gap between state medical-marijuana programs and federal veterans healthcare. Veterans can discuss cannabis with VA clinicians, and participation in a state marijuana program does not make someone ineligible for VA care or benefits. But the VA’s current published policy says its clinicians may not recommend medical marijuana or complete paperwork required for participation in state cannabis programs. That can leave Massachusetts veterans with documented conditions in their federal medical records needing to find—and potentially pay—a separate state-authorized provider simply to receive the certification required for a Massachusetts medical cannabis card.
Veterans Could Use VA Medical Documentation Instead of a Separate Cannabis Certification
Massachusetts law currently defines a qualifying medical-marijuana patient as someone diagnosed by a registered healthcare professional with a debilitating medical condition. To participate in the state program, the patient generally needs a written or electronic certification from a registered physician, physician assistant or certified nurse practitioner who has a bona fide professional relationship with the patient. The certification states that the potential benefits of medical marijuana are likely to outweigh the risks for that individual.
Healey’s bill would create an exception specifically for veterans receiving healthcare at a federal VA facility. Under Section 18 of H.5679, the Cannabis Control Commission could issue a medical registration card to a veteran who provides official VA documentation showing a diagnosis of a qualifying debilitating medical condition, without requiring a separate written or electronic cannabis certification from another healthcare professional. The legislation would also direct the Cannabis Control Commission to establish procedures and criteria for issuing cards through this new veteran pathway.
This would not eliminate medical documentation. A veteran would still need evidence of a qualifying diagnosis from the VA and would still have to obtain a Massachusetts medical-marijuana registration card. The difference is that the veteran would no longer have to duplicate the medical review through a separate provider solely because federal VA clinicians cannot complete state cannabis certification forms.
The Current System Can Create an Extra Cost for Veterans
Massachusetts no longer charges patients a state registration fee to obtain or renew a medical marijuana card. But the Cannabis Control Commission notes that healthcare professionals may charge their own fees for initial certification and annual recertification, with the amount determined by the provider. Both the provider certification and the patient’s state registration normally must remain active for continued access to the medical program.
That creates a particular issue for veterans whose regular physician is within the VA. A veteran may already have received years of treatment for chronic pain, PTSD or another condition through the federal system and have that diagnosis fully documented in VA records. Yet because VA clinicians cannot complete Massachusetts medical-marijuana paperwork, the veteran may have to establish another clinical relationship outside the VA and pay for a cannabis-specific consultation.
Healey’s proposal would effectively allow the state to recognize the underlying federal medical diagnosis while keeping the decision to issue a marijuana registration card within Massachusetts’ regulatory system. It would not require VA physicians to recommend cannabis or change federal clinical policy.
PTSD and Chronic Pain Would Be Explicitly Added to Massachusetts Law
The proposal goes beyond the registration procedure for veterans. Section 17 would amend Massachusetts’ statutory definition of a “debilitating medical condition” to specifically include post-traumatic stress disorder and medical conditions that produce chronic pain. Current law explicitly lists cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s disease, Parkinson’s disease and multiple sclerosis, while also allowing healthcare professionals to approve other conditions on an individual basis.
Under Healey’s language, PTSD and chronic pain conditions would become expressly named in statute rather than depending on the broader discretionary provision. That change could affect non-veterans as well because the revised definition applies to the medical program generally.
The distinction matters particularly for veterans because PTSD and chronic pain are common reasons veterans report using cannabis. An NIH, Defense Department and VA-supported survey of veterans with chronic pain found that 40 percent reported using cannabis, although the survey did not establish whether cannabis was effective or safe for those individuals.
The Proposal Does Not Mean VA Doctors Would Begin Prescribing Marijuana
The state legislation cannot rewrite federal VA policy. The VA’s current guidance states that clinicians may discuss marijuana with patients, record cannabis use in the medical record and modify treatment plans when appropriate. Veterans are also explicitly told that marijuana use does not by itself result in loss of VA healthcare or benefits.
However, VA clinicians still may not recommend medical marijuana, complete state marijuana forms, dispense marijuana through VA pharmacies or pay for it. Cannabis possession also remains prohibited on VA property under federal rules. Healey’s proposal works around the certification problem at the state level rather than changing those federal restrictions.
If the bill becomes law, a veteran could therefore obtain a diagnosis through ordinary VA healthcare, provide the appropriate documentation to Massachusetts and potentially receive a state cannabis card without asking a federal clinician to make a cannabis recommendation.
Massachusetts Lawmakers Have Considered the Idea Before
The concept did not originate with the September supplemental budget. Similar legislation has been pending in the Massachusetts Legislature during the current session.
House Bill 176, sponsored by Rep. Michael Soter, would also allow a veteran receiving healthcare from a federal VA facility to qualify by presenting documentation of a debilitating condition. The Joint Committee on Cannabis Policy voted 11-0 in favor of the measure in August 2025 before sending it on for further review.
A Senate version, S.79, sponsored by Sen. Ryan Fattman, is currently before the Senate Committee on Ways and Means. Its sponsor summary specifically describes the measure as streamlining medical-marijuana registration for veterans by allowing them to use their VA “Blue Button Report Problem List” to document a qualifying diagnosis.
Those bills differ slightly from Healey’s newest proposal. H.176 and S.79 would explicitly add opioid use disorder along with PTSD to the statutory list of debilitating conditions. Healey’s supplemental budget language instead names PTSD and chronic-pain conditions but does not specifically add opioid use disorder.
The Evidence for Cannabis in PTSD Remains Uncertain
Making PTSD explicitly eligible under state law should not be confused with a scientific determination that marijuana is an established PTSD treatment. The VA’s National Center for PTSD says the clinical evidence remains insufficient and notes that the VA/Department of Defense clinical guideline recommends against cannabis or cannabis derivatives as a treatment for PTSD because well-designed randomized studies demonstrating sustained benefit are lacking.
The best-known randomized trial of whole-plant cannabis in military veterans with PTSD compared high-THC, high-CBD and balanced THC/CBD cannabis with placebo. During the placebo-controlled phase, researchers did not find a significant advantage for any active cannabis preparation over placebo in reducing overall PTSD symptoms. An improvement later observed in a THC/CBD group occurred during a phase without a placebo comparator, limiting the conclusions that could be drawn.
That does not mean veterans do not report symptom relief. Observational studies and patient reports describe cannabis use for sleep, anxiety, pain and trauma-related symptoms. But those findings are different from evidence that cannabis treats the underlying disorder. Massachusetts’ proposed policy would determine eligibility and access, not establish cannabis as a first-line treatment for PTSD.
Chronic Pain Presents a Similar Evidence Question
The proposal’s addition of chronic pain reflects another major reason patients use medical cannabis, but here too the evidence is nuanced. Some cannabinoid products have demonstrated modest pain reductions in clinical trials, while results vary substantially by formulation, dose, condition and THC content.
Veterans are particularly relevant because chronic pain is widespread in the VA population. A large analysis of Veterans Health Administration records found that chronic pain diagnoses increased substantially between 2005 and 2019. The same study also found that cannabis use disorder became more common among veterans with chronic pain, underscoring the need to balance potential symptom relief against risks associated with problematic or sustained use.
A separate national VA study involving more than 1.1 million veterans prescribed opioids found measurable cannabis use across the population, with higher rates in jurisdictions where marijuana was legal. Researchers emphasized that cannabis use among veterans managing pain is already occurring regardless of whether it is formally integrated into VA treatment.
The Proposal Could Improve Coordination, but It Does Not Integrate Cannabis Into VA Care
One potential benefit of the Massachusetts approach is administrative rather than therapeutic. The veteran’s diagnosis would originate within the healthcare system already responsible for treating that patient rather than requiring a second provider to reproduce documentation. But cannabis itself would remain outside the VA healthcare system.
That separation creates its own challenges. A 2024 national study examined VA patients receiving long-term opioid therapy who tested positive for cannabis and found that about one-third had no documented cannabis-related discussion in their records during the following six months. When discussions did occur, conversations about specific medical risks or harm-reduction strategies were relatively uncommon. Researchers argued that better clinical communication is important as more veterans use cannabis while receiving other medications.
Healey’s bill would not solve that broader coordination problem. It would remove a state registration barrier, while decisions about how veterans and their VA clinicians discuss cannabis would remain governed by federal healthcare policy.
Medical Marijuana Would Still Not Be Covered by VA or Insurance
Another practical limitation is cost. Even if veterans avoid paying for an outside cannabis certification, neither the VA nor conventional insurance pays for marijuana purchased through the Massachusetts medical program. The Cannabis Control Commission explicitly states that medical-marijuana purchases are not covered by insurance.
Veterans would therefore still pay out of pocket for cannabis products. The proposal lowers one potential entry cost and administrative burden but does not convert medical marijuana into a VA-covered prescription drug.
Massachusetts medical patients do receive advantages compared with adult-use consumers, including medical-specific access rules and the ability to possess a 60-day supply of up to 10 ounces unless a healthcare professional determines a larger quantity is medically necessary.
The Bill Still Needs Legislative Approval
Healey filed the proposal as part of a much larger fiscal-year 2026 supplemental budget containing approximately $2.24 billion in gross appropriations as well as unrelated policy provisions involving healthcare, public safety, energy costs and other issues. The governor’s filing specifically describes the marijuana provision as removing obstacles to veterans obtaining medical marijuana licenses.
The measure is now formally H.5679. The Massachusetts House received it on September 24 and referred it to the House Committee on Ways and Means. The Legislature can approve the language, alter it, separate it from the spending package or decline to enact it.
If the veteran provisions survive that process, Massachusetts would create a relatively direct bridge between federal veterans healthcare records and its state medical-cannabis program: a VA diagnosis could establish the medical condition, while the Cannabis Control Commission—not a separate cannabis-certifying clinician—would determine eligibility for the state card.
For veterans already receiving treatment through the VA, that could eliminate a redundant appointment and possible certification expense. It would not amount to VA endorsement of marijuana, change federal prescribing rules or settle the medical debate around cannabis for PTSD and chronic pain. Instead, it would represent a targeted state-policy response to a federal-state mismatch that has complicated medical-cannabis access for veterans for years.
